Many people with Alzheimer''''s disease develop symptoms including delusions, agitation, aggressive behavior, or hallucinations. These symptoms add to the many difficulties of living with Alzheimer''''s disease. The CATIE Alzheimer''''s Disease Study aims to find out the most effective medication treatments for these symptoms, and to improve the quality of life of people with Alzheimer''''s disease, their families, and caregivers. The last CATIE-AD patient completed the trial in October. Over the last few months, we have been working assiduously to lock the database and check the analysis programming. CATIE-AD is a trial that will provide layers of results. The complex outcomes will depend not only on randomized treatment assignment but the interactions of the clinical sites with the patients and caregivers. The main goals are to generate hypotheses about effectiveness and other issues with antipsychotic use that might undergo future testing. Dissemination of outcomes from CATIE-AD will be rolled out over the next 8 months at several meetings. (2005) Additional information may be found by following the links, http://www.nimh.nih.gov/trials/practical/catie/index.shtml, http://www.clinicaltrials.gov/ct2/show/NCT00015548?term=CATIE&rank=2
Resource Type: Resource
Version: Latest Version
SciCrunch is a data sharing and display platform. Anyone can create a custom portal where they can select searchable subsets of hundreds of data sources, brand their web pages and create their community. SciCrunch will push data updates automatically to all portals on a weekly basis. User communities can also add their own data to scicrunch, however this is not currently a free service.